We are live on ! Find out more
FULC icon

Fulcrum Therapeutics
FULC

110 hedge funds and large institutions have $366M invested in Fulcrum Therapeutics in 2022 Q4 according to their latest regulatory filings, with 22 funds opening new positions, 47 increasing their positions, 25 reducing their positions, and 17 closing their positions.

New
Increased
Maintained
Reduced
Closed

1,008% more call options, than puts

Call options by funds: $4.21M | Put options by funds: $380K

88% more repeat investments, than reductions

Existing positions increased: 47 | Existing positions reduced: 25

29% more first-time investments, than exits

New positions opened: 22 | Existing positions closed: 17

5% more funds holding

Funds holding: 105 → 110 (+5)

0% more funds holding in top 10

Funds holding in top 10: 2 → 2 (0)

5.85% less ownership

Funds ownership: 103.13% → 97.28% (-5.8%)

13% less capital invested

Capital invested by funds: $422M → $366M (-$56.5M)

Holders
110
Holders Change
+5
Holders Change %
+4.76%
% of All Funds
1.77%
Holding in Top 10
2
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.03%
New
22
Increased
47
Reduced
25
Closed
17
Calls
$4.21M
Puts
$380K
Net Calls
+$3.83M
Net Calls Change
-$1.01M

Top Buyers

Rank Fund Capital Flow
1
RCM
RA Capital Management
Massachusetts
+$16.3M
2
RI
RTW Investments
New York
+$6.57M
3
SCM
Suvretta Capital Management
New York
+$4.87M
4
NCM
Nantahala Capital Management
Connecticut
+$3.26M
5
BlackRock
BlackRock
New York
+$3.24M

Top Sellers

Rank Fund Capital Flow
1
Fidelity Investments
Fidelity Investments
Massachusetts
-$16.8M
2
TGI
TRV GP III
Massachusetts
-$13M
3
Point72 Asset Management
Point72 Asset Management
Connecticut
-$12.1M
4
CAC
Cowen and Company
New York
-$6.44M
5
VA
VR Adviser
New York
-$4.91M
Name Holding Trade Value Shares
Change 		Change in
Stake
PP
51
PDT Partners
New York
$301K +$270K +41,403 New
BCM
52
Bridgeway Capital Management
Texas
$291K -$228K -35,000 -47%
AA
53
ALPS Advisors
Colorado
$257K +$231K +35,358 New
CIC
54
Cornercap Investment Counsel
Georgia
$254K +$228K +34,886 New
XT
55
XTX Topco
Cayman Islands
$254K +$227K +34,882 New
VOYA Investment Management
56
VOYA Investment Management
Georgia
$254K +$51.9K +7,962 +30%
Stifel Financial
57
Stifel Financial
Missouri
$250K +$11.1K +1,700 +5%
CSS
58
Cubist Systematic Strategies
Connecticut
$224K -$38.1K -5,839 -16%
CTB
59
Country Trust Bank
Illinois
$220K – – –
BM
60
Brandywine Managers
Delaware
$190K – – –
OQS
61
Occudo Quantitative Strategies
Florida
$189K -$43.3K -6,636 -20%
PAM
62
Panagora Asset Management
Massachusetts
$169K -$38K -5,825 -20%
GCM
63
Graham Capital Management
Connecticut
$155K +$139K +21,353 New
Ameriprise
64
Ameriprise
Minnesota
$153K +$2.15K +330 +2%
AIG
65
American International Group
New York
$150K +$28.6K +4,386 +27%
Blackstone Inc
66
Blackstone Inc
New York
$140K +$125K +19,216 New
MIM
67
MetLife Investment Management
New Jersey
$138K – – –
Deutsche Bank
68
Deutsche Bank
Germany
$137K -$32.4K -4,962 -21%
New York State Common Retirement Fund
69
New York State Common Retirement Fund
New York
$136K +$26 +4 +0%
OWP
70
Old Well Partners
North Carolina
$126K +$113K +17,300 New
Manulife (Manufacturers Life Insurance)
71
Manulife (Manufacturers Life Insurance)
Ontario, Canada
$124K +$13.1K +2,009 +13%
SG Americas Securities
72
SG Americas Securities
New York
$117K +$27.4K +4,198 +35%
AGM
73
Alpine Global Management
New York
$117K +$105K +16,073 New
Marshall Wace
74
Marshall Wace
United Kingdom
$113K -$29.9K -4,589 -23%
UBS AM
75
UBS AM
Illinois
$108K – – –
1 2
3
4 5

FULC Hedge Fund Activity: Q4 2022 in Review

110 of the 6,221 institutional investors tracked by Wall St. Rank reported a position in Fulcrum Therapeutics (FULC) for Q4 2022, worth a combined $366M — down 13% from $422M a quarter earlier.

Buyers outnumbered sellers: 22 funds opened new FULC positions and 17 closed out — a net gain of 5 holders — while 47 added to existing stakes and 25 trimmed.

The largest buyer was RA Capital Management, adding an estimated $16.3M. The largest seller was Fidelity Investments, cutting an estimated $16.8M.

  • 110 institutional investors held Fulcrum Therapeutics (FULC) as of Q4 2022, up from 105 in Q3 2022.
  • Funds reported $366M of Fulcrum Therapeutics stock for Q4 2022, down 13% quarter-over-quarter.
  • 22 funds opened new Fulcrum Therapeutics positions in Q4 2022 and 17 closed out, a net change of +5 holders.
  • The largest Fulcrum Therapeutics buyer in Q4 2022 was RA Capital Management, an estimated $16.3M added.
  • The largest Fulcrum Therapeutics seller in Q4 2022 was Fidelity Investments, an estimated $16.8M sold.

Based on aggregated 13F filings for Q4 2022.